MNA
CLBT icon

Manning & Napier Advisors’s Cellebrite CLBT Stock Holding History

Manning & Napier Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-145,541
Closed -$2.62M – 619
2025
Q4 		$2.62M Sell
145,541
-5,779
-4% -$104K 0.03% 203
2025
Q3 		$2.8M Buy
151,320
+92,270
+156% +$1.45M 0.04% 199
2025
Q2 		$945K Sell
59,050
-42,798
-42% -$763K 0.01% 255
2025
Q1 		$1.98M Buy
+101,848
New +$2.14M 0.02% 226

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Manning & Napier Advisors's CLBT Position: Q1 2026 in Review

Manning & Napier Advisors sold out of Cellebrite (CLBT) in Q1 2026, closing a stake of 145,541 shares — an estimated $2.62M sold.

Manning & Napier Advisors first reported a position in CLBT in Q1 2025 and held it in 4 quarters. The position peaked at $2.8M in Q3 2025. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Manning & Napier Advisors reported no remaining Cellebrite position as of Q1 2026 after selling out during the quarter.
  • Manning & Napier Advisors sold 145,541 Cellebrite shares in Q1 2026, an estimated $2.62M.
  • Manning & Napier Advisors first reported a position in Cellebrite in Q1 2025 and held it in 4 quarters.
  • Manning & Napier Advisors's Cellebrite position peaked at $2.8M in Q3 2025.
  • 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Manning & Napier Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.